01:35 AM EDT, 09/16/2026 (MT Newswires) -- Median Technologies (ALMDT.PA) secured an 8.4 million-euro contract for its iCRO business unit from an existing customer operating in the European pharmaceutical sector. The contract covers comprehensive central imaging services and advanced image analyses for a phase three oncology imaging project to evaluate an investigational treatment for a rare form of brain cancer, the medical technology company said Tuesday. Median Technologies added that the contract will expand iCRO's order backlog and provide additional revenue visibility.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.